Characterisation, solubility and intrinsic dissolution behaviour of benzamide: Dibenzyl sulfoxide cocrystal

International Journal of Pharmaceutics

Volumn 422, Issue 1-2, 2012, Pages 24-32

  Grossjohann, Christine ^a   Eccles, Kevin S ^b   Maguire, Anita R ^b   Lawrence, Simon E ^b   Tajber, Lidia ^a   Corrigan, Owen I ^a   Healy, Anne Marie ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Cocrystals; Complexation; HPLC; Intrinsic dissolution; Solubility

Indexed keywords

BENZAMIDE;

ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; DISSOLUTION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; ENERGY DISPERSIVE X RAY DIFFRACTION; FOURIER TRANSFORM MASS SPECTROMETRY; INFRARED SPECTROMETRY; KINETICS; PRIORITY JOURNAL; THERMAL ANALYSIS; X RAY DIFFRACTION; X RAY POWDER DIFFRACTION;

BENZAMIDES; BENZYL COMPOUNDS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; DRUG STABILITY; KINETICS; MODELS, CHEMICAL; POWDER DIFFRACTION; SOLUBILITY; SPECTROMETRY, X-RAY EMISSION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SULFOXIDES; TECHNOLOGY, PHARMACEUTICAL; THERMOGRAVIMETRY;

EID: 84655169885     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.10.016     Document Type: Article

References (46)

1. A. Ainouz, J.-R. Authelin, P. Billot, and H. Lieberman Modeling and prediction of cocrystal phase diagrams Int. J. Pharm. 374 2009 82 89
2. A. Alhalaweh, and S.P. Velaga Formation of cocrystals from stoichiometric solutions of incongruently saturating systems by spray drying Cryst. Growth Des. 10 2010 3302 3305
3. A. Avdeef, and O. Tsinman Miniaturized rotating disk intrinsic dissolution rate measurement: effects of buffer capacity in comparisons to traditional wood's apparatus Pharm. Res. 25 2008 2613 2627
4. R.D. Bailey Walsh, M.W. Bradner, S. Fleischman, L.A. Morales, B. Moulton, N. Rodríguez-Hornedo, and M.J. Zaworotko Crystal engineering of the composition of pharmaceutical phases Chem. Commun. 9 2003 186 187 (Pubitemid 36138703)
5. S.M. Berge, L.D. Bighley, and D.C. Monkhouse Pharmaceutical salts J. Pharm. Sci. 66 1977 1 19
6. S. Besavoju, D. Bostroem, and S.P. Velaga Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization Pharm. Res. 25 2008 530 541 (Pubitemid 351357724)
7. L.D. Bighley, S.M. Berge, and D.C. Monkhouse Presevation of pharmacuetical products to salt forms of drugs and absorption J. Swarbrick, J.C. Boylan, Encycolpedia of Pharmaceutical Technology vol. 13 1996 Marcel Dekker New York 453 499
8. R.A. Chiarella, R.J. Davey, and M.L. Peterson Making co-crystals - the utility of ternary phase diagrams Cryst. Growth Des. 7 2007 1223 1226
9. S.L. Childs, L.J. Chyall, J.T. Dunlap, V.N. Smolenskaya, B.C. Stahly, and G.P. Stahly Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic and fumaric acids J. Am. Chem. Soc. 126 2004 13335 13342 (Pubitemid 39382761)
10. K.S. Eccles, C.J. Elcoate, S.P. Stokes, A.R. Maguire, and S.E. Lawrence Sulfoxides: potent co-crystal formers Cryst. Growth Des. 10 2010 4243 4245
11. D.J. Good, and N. Rodríguez-Hornedo Solubility advantage of pharmaceutical cocrystals Cryst. Growth Des. 9 2009 2252 2264
12. D.J. Good, and N. Rodríguez-Hornedo Cocrystal eutectic constants and prediction of solubility behavior Cryst. Growth Des. 10 2010 1028 1032
13. A.M. Healy, and O.I. Corrigan Predicting the dissolution rate of ibuprofen-acidic excipient compressed mixtures in reactive media Int. J. Pharm. 84 1992 167 173
14. A.M. Healy, and O.I. Corrigan The influence of excipient particle size, solubility and acid strength on the dissolution of an acidic drug from two-component compacts Int. J. Pharm. 143 1996 211 221 (Pubitemid 26425827)
15. A.M. Healy, L.G. McCarthy, K.M. Gallagher, and O.I. Corrigan Sensitivity of dissolution rate to location in the paddle dissolution apparatus J. Pharm. Pharmacol. 54 2002 441 444 (Pubitemid 34232346)
16. B.A. Hendriksen, and J.D. Williams Characterization of calcium fenoprofen 2. Dissolution from formulated tablets and compressed rotating discs Int. J. Pharm. 69 1991 175 180
17. M.B. Hickey, M.L. Peterson, L.A. Scoppettuolo, S.L. Morrisette, A. Vetter, H. Guzman, J.F. Remenar, Z. Zhang, M.D. Tawa, S. Haley, M.J. Zaworotko, and O. Almarsson Performance comparison of a co-crystal of carbamazepine with marketed product Eur. J. Pharm. Biopharm. 67 2007 112 119 (Pubitemid 46991320)
18. T. Higuchi Mechanism of sustained-action medication. Theorectical analysis of rate J. Pharm. Sci. 52 1963 1145 1149
19. T. Higuchi, and K.A. Connors Phase solubility techniques Adv. Anal. Chem. Instrum. 4 1965 117 212
20. W.I. Higuchi, N.A. Mir, and S.J. Desai Dissolution rates of polyphase mixtures J. Pharm. Sci. 54 1965 1405 1410
21. W.I. Higuchi Diffusional models useful in biopharmaceutics. Drug release rate processes Pharm. Sci. 56 1967 315 324
22. M.S. Jung, J.S. Kim, M.S. Kim, A. Alhalaweh, W. Cho, S.J. Hwang, and S.P. Velaga Bioavailability of indomethacin-saccharin cocrystals J. Pharm. Pharmacol. 62 2010 1560 1568
23. F.A. Kuliev, A.D. Aslanov, and E.T. Denisov Synthesis and spectra of dibenzyl sulfoxides and sulfones Azerbaidzhanskii Khimicheskii Zhurnal 1 1984 72 75
24. H.-G. Lee, G.G.Z. Zhang, and D.R. Flanagan Cocrystal intrinsic dissolution behavior using a rotating disk J. Pharm. Sci. 100 2011 1736 1744
25. J. Lu, and S. Rohani Preparation and characterization of theophylline-nicotinamide cocrystal Org. Process Res. Dev. 13 2009 1269 1275
26. S.G. Machatha, T. Sanghvi, and S.H. Yalkowsky Structure determination and characterization of carbendazim hydrochloride dihydrate AAPS Pharm. Sci. Tech. 6 2005 E115 E119
27. J. Mauger, J. Ballard, R. Brockson, S. De, V. Gray, and D. Robinson Intrinsic dissolution performance testing of the USP dissolution apparatus 2 (rotating paddle) using modified salicylic acid calibrator tablets: proof of principal Dissolution Technol. 10 2003 6 15
28. D.P. McNamara, S.L. Childs, J. Giordano, A. Iarriccio, J. Cassidy, M.S. Shet, R. Mannion, E. O'Donnell, and A. Park Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API Pharm. Res. 2 2006 1888 1897 (Pubitemid 44200553)
29. S.J. Nehm, B. Rodríguez-Spong, and N. Rodríguez-Hornedo Phase solubility diagrams of cocrystals are explained by solubility product and solution complexation Cryst. Growth Des. 6 2006 592 600 (Pubitemid 43242126)
30. M. Nicklasson, A. Brodin, and H. Nyqvist Studies on the relationship between solubility and intrinsic rate of dissolution as a function of pH Acta Pharm. Suec. 18 1981 119 128 (Pubitemid 11032831)
31. K.M. O'Connor, and O.I. Corrigan Preparation and characterisation of a range of diclofenac salts Int. J. Pharm. 226 2001 163 179 (Pubitemid 32800791)
32. M.J. O'Neil, P.E. Heckelman, C.B. Koch, and K.J. Roman The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals 14th ed. 2006 Merck & Co. Inc. Whitehouse Station, NJ, USA
33. L. Padrela, M.A. Rodrigues, S.P. Velaga, H.A. Matos, and E. Gomes de Azevedo Formation of indomethacin-saccharin cocrystals using supercritical fluid technology Eur. J. Pharm. Sci. 38 2009 9 17
34. K.J. Paluch, L. Tajber, C.J. Elcoate, O.I. Corrigan, S.E. Lawrence, and A.M. Healy Solid-state characterization of novel active pharmaceutical ingredients: cocrystal of a salbutamol hemiadipate salt with adipic acid (2:1:1) and salbutamol hemisuccinate salt J. Pharm. Sci. 2011 10.1002/jps.22569
35. Z. Rahman, R. Samy, V.A. Sayeed, and M.A. Khan Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin Pharm. Dev. Technol. 2011 1 9
36. L.S. Reddy, S.J. Bethune, J.W. Kampf, and N. Rodríguez-Hornedo Cocrystals and salts of gabapentin: pH dependent cocrystal stability and solubility Cryst. Growth Des. 9 2009 378 385
37. N. Schultheiss, and A. Newman Pharmaceutical cocrystals and their physicochemical properties Cryst. Growth Des. 9 2009 2950 2967
38. P.H. Stahl, and C.G. Wermuth Handbook of Pharmaceutical Salts: Properties, Selection and Use 2002 Wiley-VCH/VHCA Weinheim/Zürich
39. L. Tajber, O.I. Corrigan, and A.M. Healy Physicochemical evaluation of PVP-thiazide diuretic interactions in co-spray-dried composites - analysis of glass transition composition relationships Eur. J. Pharm. Sci. 24 2005 553 563 (Pubitemid 40387269)
40. L. Tajber, D.O. Corrigan, O.I. Corrigan, and A.M. Healy Spray drying of budesonide, formoterol fumarate and their composites - I. Physicochemical characterisation Int. J. Pharm. 367 2009 79 85
41. A.V. Trask, W.D. Samuel Motherwell, and W. Jones Pharmaceutical cocrystallization: engineering a remedy for caffeine hydration Cryst. Growth Des. 5 2005 1013 1021 (Pubitemid 40755572)
42. A.V. Trask An overview of pharmaceutical cocrystals as intellectual property J. Am. Chem. Soc. 4 2007 301 309 (Pubitemid 46983946)
43. M. Wenger, and J. Bernstein An alternate crystal form of gabapentin: a cocrystal with oxalic acid Cryst. Growth Des. 8 2008 1595 1598
44. C.G. Wermuth The Practice of Medicinal Chemistry 3rd ed. 2008 Elsevier Ltd. p. 750
45. J.H. Wood, J.E. Syarto, and H. Letterman Improved holder for intrinsic dissolution rate studies J. Pharm. Sci. 54 1965 1068
46. L.X. Yu, A.S. Carlin, G.L. Amidon, and A.S. Hussain Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs Int. J. Pharm. 270 2004 221 227 (Pubitemid 38077102)